Introduction {#s0001}
============

Neurofibroma is a benign neoplasm of the peripheral nerves, which often presents as a variant of neurofibromatosis type-1 (NF-1). The tumor arises ubiquitously in the skin of any body part; however, subungual tumors are rare. In fact, only few cases of solitary subungual neurofibroma have been reported previously. We herein report a case of solitary subungual neurofibroma in a middle-aged woman, with a preoperative diagnosis of glomus tumor.

Case report {#s0002}
===========

A 62-year-old woman presented with a two-year history of a slow-growing, painless, pale-red subungual tumor of the left thumb and distal nail splitting. She had no history of preceding trauma to the finger. The tumor was 4 mm in diameter and the nail bed proximal to the tumor was slightly elevated ([Figure 1(A)](#F0001){ref-type="fig"}). The tumor could easily be perceived. Radiographic examination showed no bone defects and magnetic resonance imaging (MRI) showed a small space-occupying lesion adjacent to the proximal part of the distal phalanx. The tumor presented with normal intensity on T1-weighed image ([Figure 1(B)](#F0001){ref-type="fig"}) and was hyperintense on T2-weighed image ([Figure 1(C)](#F0001){ref-type="fig"}). A flow void was observed in the tumor, suggesting the presence of intratumor blood flow.

![Clinical findings and MRI images. (A) A reddish mass of 4-mm diameter is seen under the nail plate (area surrounded by the triangle mark). Distal nail splitting is observed in the left thumb. (B) T1-weighed magnetic resonance image shows tumor with normal intensity. (C) T2-weighed magnetic resonance image shows high-intensity lesion. Flow void is indicated by an arrow. MRI: magnetic resonance imaging.](ICRP_A_1750018_F0001_C){#F0001}

We performed a surgical excision of this tumor under local anesthesia. After the nail claw, the skin overlying the nail matrix was lifted. On gross observation, the tumor was smooth, pale-yellow in color, well-circumscribed and did not invaded the bone. The tumor could be resected completely ([Figure 2(A)](#F0002){ref-type="fig"}). The defective nail matrix was reconstructed with a glabrous dermal graft ([Figure 2(B)](#F0002){ref-type="fig"}) taken from the thenar of the right thumb.

![Surgical findings. (A) A reddish mass is seen under the nail plate. The excision line after the nail claw is indicated in blue. (B) After excision, skin grafting was performed from the thenar eminence.](ICRP_A_1750018_F0002_C){#F0002}

Histological examination of the excised specimen showed an incompletely encapsulated eosinophilic fibrous tumor ([Figure 3(A)](#F0003){ref-type="fig"}). The tumor was composed of fine collagen fibers with numerous scattered cells with spindle- and comma-shaped nuclei ([Figure 3(B,C](#F0003){ref-type="fig"}). A small number of the mast cells were observed within the tumor ([Figure 3(C)](#F0003){ref-type="fig"}). The histological diagnosis was neurofibroma and the final diagnosis of the patient was solitary subungual neurofibroma. Postoperatively, the nail re-grew with a good cosmetic result ([Figure 3(D)](#F0003){ref-type="fig"}). Tumor recurrence was not observed even at postoperative 6-month follow-up.

![Histopathological findings. (A) A loupe image. An incompletely encapsulated tumor. (B) A middle-power view. The tumor is composed of fine collagen fibers pointed in every direction. (C) A high-power view. Nuclei of the proliferating cells are spindle- or comma-shaped. Among the tumor cells, capillaries and a small number of mast cells are dispersed (indicated by arrows). (D) Appearance of new thumb nail six months postoperatively. This observation is natural.](ICRP_A_1750018_F0003_C){#F0003}

Discussion {#s0003}
==========

Solitary subungual neurofibroma is a rare condition. In 1981, Runne and Orfanos first described a case of neurofibroma in the nail bed \[[@CIT0001]\]. Till date, only 10 cases have been reported \[[@CIT0002],[@CIT0003]\]. Roldan-Marin et al. reported the clinical features of solitary subungual neurofibroma \[[@CIT0004]\]. They described the following characteristics: (1) occurs in middle-aged females; (2) occurs in the fingers and toes; (3) asymptomatic; and (4) postoperative recurrence after surgical resection is rare. The present case had similar presentations.

A clinical diagnosis of solitary subungual neurofibroma before histological examination of the tumor is difficult because it is rare and does not usually demonstrate pathognomonic symptoms \[[@CIT0005]\]. The present patient was considered to be a case of glomus tumor because of the subungual preponderance of the tumor \[[@CIT0006]\]. However, because the lesion was painless, the tentative diagnosis was suspicious. Among the past reports, only two of the ten patients presented obvious pain \[[@CIT0004],[@CIT0007]\]. Furthermore, glomus tumor causes nail plate deformity similar to that observed in the present case; therefore, it is difficult to differentially diagnose glomus tumor with subungual neurofibroma. Three previously reported cases showed thickening and elevation of the nail plate \[[@CIT0004],[@CIT0008],[@CIT0009]\], while nail dystrophy was reported in five cases \[[@CIT0003],[@CIT0004],[@CIT0007],[@CIT0010]\], including the present case. Only one case had no nail plate deformity \[[@CIT0005]\]. MRI findings of normal intensity in T1-weighed image, high intensity in T2-weighed image and presence of intra-tumoral flow void were indicative of both neurofibroma and glomus tumor. Thus, differential diagnosis of these tumors by medical imaging techniques is difficult. A promising feature that supports a diagnosis of glomus tumor is the classical triad of the following symptoms: temperature sensitivity, pain and localized tenderness in the finger \[[@CIT0006]\]. The absence of the pain in the present case would have completed the classic triad of glomus tumor and made diagnosis extremely reliable. We reported a case of rare solitary subungual neurofibroma with a differential diagnosis of glomus tumor. The presence or absence of the pain would be a reliable differentiator of these tumors.
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